Guggenheim downgraded Q32 Bio (QTTB) to Neutral from Buy.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB:
- Q32 Bio price target lowered to $20 from $80 at Oppenheimer
- Q32 Bio Announces Mixed Results in Clinical Trials
- Q32 Bio price target lowered to $20 from $85 at Piper Sandler
- Q32 Bio downgraded to Market Perform from Outperform at Leerink
- Q32 Bio downgraded to Outperform from Strong Buy at Raymond James
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue